BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 31072408)

  • 1. Human lung fibroblast-to-myofibroblast transformation is not driven by an LDH5-dependent metabolic shift towards aerobic glycolysis.
    Schruf E; Schroeder V; Kuttruff CA; Weigle S; Krell M; Benz M; Bretschneider T; Holweg A; Schuler M; Frick M; Nicklin P; Garnett JP; Sobotta MC
    Respir Res; 2019 May; 20(1):87. PubMed ID: 31072408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 3-Bromopyruvate decreased kidney fibrosis and fibroblast activation by suppressing aerobic glycolysis in unilateral ureteral obstruction mice model.
    Yu H; Zhu J; Chang L; Liang C; Li X; Wang W
    Life Sci; 2021 May; 272():119206. PubMed ID: 33577854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lactic acid is elevated in idiopathic pulmonary fibrosis and induces myofibroblast differentiation via pH-dependent activation of transforming growth factor-β.
    Kottmann RM; Kulkarni AA; Smolnycki KA; Lyda E; Dahanayake T; Salibi R; Honnons S; Jones C; Isern NG; Hu JZ; Nathan SD; Grant G; Phipps RP; Sime PJ
    Am J Respir Crit Care Med; 2012 Oct; 186(8):740-51. PubMed ID: 22923663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HuR drives lung fibroblast differentiation but not metabolic reprogramming in response to TGF-β and hypoxia.
    Trivlidis J; Aloufi N; Al-Habeeb F; Nair P; Azuelos I; Eidelman DH; Baglole CJ
    Respir Res; 2021 Dec; 22(1):323. PubMed ID: 34963461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DOCK2 contributes to pulmonary fibrosis by promoting lung fibroblast to myofibroblast transition.
    Guo X; Adeyanju O; Sunil C; Mandlem V; Olajuyin A; Huang S; Chen SY; Idell S; Tucker TA; Qian G
    Am J Physiol Cell Physiol; 2022 Jul; 323(1):C133-C144. PubMed ID: 35584329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lung myofibroblasts are characterized by down-regulated cyclooxygenase-2 and its main metabolite, prostaglandin E2.
    Gabasa M; Royo D; Molina-Molina M; Roca-Ferrer J; Pujols L; Picado C; Xaubet A; Pereda J
    PLoS One; 2013; 8(6):e65445. PubMed ID: 23755232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MARCH8 downregulation modulates profibrotic responses including myofibroblast differentiation.
    Guo X; Adeyanju O; Olajuyin AM; Mandlem V; Sunil C; Adewumi J; Huang S; Tucker TA; Idell S; Qian G
    Am J Physiol Cell Physiol; 2023 Nov; 325(5):C1190-C1200. PubMed ID: 37661917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-fibrotic effect of iguratimod on pulmonary fibrosis by inhibiting the fibroblast-to-myofibroblast transition.
    Lin H; Wu C; Zhu F; Zhang G; Xie Y; Cui Y; Dong G; Zhang X
    Adv Med Sci; 2020 Sep; 65(2):338-347. PubMed ID: 32590154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arsenic trioxide inhibits transforming growth factor-β1-induced fibroblast to myofibroblast differentiation in vitro and bleomycin induced lung fibrosis in vivo.
    Luo F; Zhuang Y; Sides MD; Sanchez CG; Shan B; White ES; Lasky JA
    Respir Res; 2014 Apr; 15(1):51. PubMed ID: 24762191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic reprogramming of glycolysis and glutamine metabolism are key events in myofibroblast transition in systemic sclerosis pathogenesis.
    Henderson J; Duffy L; Stratton R; Ford D; O'Reilly S
    J Cell Mol Med; 2020 Dec; 24(23):14026-14038. PubMed ID: 33140521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TGF-β1/SMOC2/AKT and ERK axis regulates proliferation, migration, and fibroblast to myofibroblast transformation in lung fibroblast, contributing with the asthma progression.
    Wang Y; Yang H; Su X; Cao A; Chen F; Chen P; Yan F; Hu H
    Hereditas; 2021 Dec; 158(1):47. PubMed ID: 34876240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistent hypoxia promotes myofibroblast differentiation via GPR-81 and differential regulation of LDH isoenzymes in normal and idiopathic pulmonary fibrosis fibroblasts.
    Nho RS; Rice C; Prasad J; Bone H; Farkas L; Rojas M; Horowitz JC
    Physiol Rep; 2023 Sep; 11(17):e15759. PubMed ID: 37653539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apigenin inhibits TGF-β1 induced fibroblast-to-myofibroblast transition in human lung fibroblast populations.
    Wójcik KA; Skoda M; Koczurkiewicz P; Sanak M; Czyż J; Michalik M
    Pharmacol Rep; 2013; 65(1):164-72. PubMed ID: 23563034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymer-Functionalized Mitochondrial Transplantation to Fibroblasts Counteracts a Pro-Fibrotic Phenotype.
    Baudo G; Wu S; Massaro M; Liu H; Lee H; Zhang A; Hamilton DJ; Blanco E
    Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37446100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibiting aerobic glycolysis suppresses renal interstitial fibroblast activation and renal fibrosis.
    Ding H; Jiang L; Xu J; Bai F; Zhou Y; Yuan Q; Luo J; Zen K; Yang J
    Am J Physiol Renal Physiol; 2017 Sep; 313(3):F561-F575. PubMed ID: 28228400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TGF-β1-induced miR-424 promotes pulmonary myofibroblast differentiation by targeting Slit2 protein expression.
    Huang Y; Xie Y; Abel PW; Wei P; Plowman J; Toews ML; Strah H; Siddique A; Bailey KL; Tu Y
    Biochem Pharmacol; 2020 Oct; 180():114172. PubMed ID: 32712053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxymatrine Inhibits Transforming Growth Factor β1 (TGF-β1)-Induced Cardiac Fibroblast-to-Myofibroblast Transformation (FMT) by Mediating the Notch Signaling Pathway In Vitro.
    Zhao L; Xu Y; Tao L; Yang Y; Shen X; Li L; Luo P
    Med Sci Monit; 2018 Sep; 24():6280-6288. PubMed ID: 30196308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AITC inhibits fibroblast-myofibroblast transition via TRPA1-independent MAPK and NRF2/HO-1 pathways and reverses corticosteroids insensitivity in human lung fibroblasts.
    Yap JMG; Ueda T; Kanemitsu Y; Takeda N; Fukumitsu K; Fukuda S; Uemura T; Tajiri T; Ohkubo H; Maeno K; Ito Y; Oguri T; Ugawa S; Niimi A
    Respir Res; 2021 Feb; 22(1):51. PubMed ID: 33579280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacologic inhibition of lactate production prevents myofibroblast differentiation.
    Kottmann RM; Trawick E; Judge JL; Wahl LA; Epa AP; Owens KM; Thatcher TH; Phipps RP; Sime PJ
    Am J Physiol Lung Cell Mol Physiol; 2015 Dec; 309(11):L1305-12. PubMed ID: 26408551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycolytic Reprogramming in Myofibroblast Differentiation and Lung Fibrosis.
    Xie N; Tan Z; Banerjee S; Cui H; Ge J; Liu RM; Bernard K; Thannickal VJ; Liu G
    Am J Respir Crit Care Med; 2015 Dec; 192(12):1462-74. PubMed ID: 26284610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.